The term calpainopathy was coined to identify the cluster of signs and symptoms that define the phenotype that originated as consequence of pathogenic mutations that are harbored in the CAPN3 gene. This evidence concerns the gene CAPN3 and autosomal recessive limb-girdle muscular dystrophy type 2A.